Natural Health Trends (NAH) Q2 2026 Earnings Report

The call presented a mix of operational improvements and new product momentum (margin expansion, restructuring savings, improved operating cash flow, product launch, and share repurchase authorization), but these positives were overshadowed by a pronounced revenue decline (-23% year-over-year), a swing to net loss, increased operating loss, significant cash reduction since year-end, and ongoing China-related headwinds and member misconduct that disrupted business. While management is taking disciplined steps to improve efficiency and engagement, near-term financial performance and market challenges weigh heavily on the outlook.

The guidance emphasized financial discipline and execution to drive savings and position the business for recovery: Q2 net sales were $7.6M (down 23% YoY) while gross margin improved to 75.2% from 73.9% and commissions remained 40.9% of revenue; restructuring delivered roughly $300K of savings in the quarter and more than $600K year-to-date with additional savings expected in the second half, SG&A was $3.3M (down $323K YoY), operating loss was $643K (net loss $451K, or $0.05 per diluted share, versus net income $15K prior-year), and the company reported $18.6M of cash and marketable securities at June 30 (down from $28.9M at Dec. 31, 2025) after repurchases and dividends, used $2.2M of operating cash in the first six months (vs $5.2M a year earlier), resumed share repurchases with $15.9M available, and plans customer- and field-focused initiatives (including a 25th‑anniversary event expected to draw more than 1,000 attendees) to support long-term growth.